LONDON (AFX) - Croatia's pharmaceutical company Pliva said it received a warning letter from the US Food and Drug Administration regarding the inspection of its manufacturing facility in Zagreb. The company said management is addressing this issue 'very seriously' and is implementing a corrective action plan submitted in April and been accepted by the FDA 'except as stated in the warning letter'.
